These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Improvement in conditions for solubilisation and characterisation of brain D2 dopamine receptors using various detergents. Wheatley M, Hall JM, Frankham PA, Strange PG. J Neurochem; 1984 Oct; 43(4):926-34. PubMed ID: 6470714 [Abstract] [Full Text] [Related]
7. Optimisation of conditions for solubilisation of the bovine dopamine D2 receptor. Hooper RJ. J Neurochem; 1986 Oct; 47(4):1080-5. PubMed ID: 2943871 [Abstract] [Full Text] [Related]
8. Characterization of cholate-solubilized dopamine receptors from human, dog and rat brain. Wouters W, van Dun J, Laduron PM. Biochem Pharmacol; 1984 Dec 15; 33(24):4039-44. PubMed ID: 6508850 [Abstract] [Full Text] [Related]
9. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes. Clagett-Dame M, Schoenleber R, Chung C, McKelvy JF. Biochim Biophys Acta; 1989 Nov 27; 986(2):271-80. PubMed ID: 2531613 [Abstract] [Full Text] [Related]
10. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM. Schonwetter BS, Luedtke RR, Kung MP, Billings J, Kung HF, Molinoff PB. J Pharmacol Exp Ther; 1989 Jul 27; 250(1):110-6. PubMed ID: 2526213 [Abstract] [Full Text] [Related]
11. Solubilization of brain alpha-2 adrenoceptor with a zwitterionic detergent: preservation of agonist binding and its sensitivity to GTP. Sladeczek F, Bockaert J, Rouot B. Biochem Biophys Res Commun; 1984 Mar 30; 119(3):1116-21. PubMed ID: 6324778 [Abstract] [Full Text] [Related]
13. Use of cholate/sodium chloride for solubilisation of brain D2 dopamine receptors. Hall JM, Frankham PA, Strange PG. J Neurochem; 1983 Dec 30; 41(6):1526-32. PubMed ID: 6644296 [Abstract] [Full Text] [Related]
14. Affinity chromatography of the anterior pituitary D2-dopamine receptor. Senogles SE, Amlaiky N, Johnson AL, Caron MG. Biochemistry; 1986 Feb 25; 25(4):749-53. PubMed ID: 2938619 [Abstract] [Full Text] [Related]
16. Comparison of soluble dopamine D2-receptors from three species. Madras BK, Davis A, Seeman P. Eur J Pharmacol; 1982 Mar 26; 78(4):431-8. PubMed ID: 7075677 [Abstract] [Full Text] [Related]
17. Solubilization and characterization of D2-dopamine receptors in an estrone-induced, prolactin-secreting rat pituitary adenoma. Bouvier C, Potier M, Beauregard G, Lafond J, Amlaiky N, Caron MG, Collu R. J Neurochem; 1986 Nov 26; 47(5):1653-60. PubMed ID: 3760878 [Abstract] [Full Text] [Related]
18. Characterisation of brain D2 dopamine receptors solubilised by lysophosphatidylcholine. Wheatley M, Strange PG. FEBS Lett; 1983 Jan 10; 151(1):97-101. PubMed ID: 6186527 [Abstract] [Full Text] [Related]
19. Characterization of binding sites for [3H]spiroperidol. Luedtke RR, Molinoff PB. Biochem Pharmacol; 1987 Oct 01; 36(19):3255-64. PubMed ID: 2959288 [Abstract] [Full Text] [Related]
20. Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells. Miquel MC, Emerit MB, Bolaños FJ, Schechter LE, Gozlan H, Hamon M. J Neurochem; 1990 Nov 01; 55(5):1526-36. PubMed ID: 2213008 [Abstract] [Full Text] [Related] Page: [Next] [New Search]